Zealthy review

Give the membership a defined clinical purpose

Zealthy combines clinical access, coaching and coverage coordination. Those services can help organize a weight-care plan, but their availability does not establish a prevention programme or a benefit to function or lifespan. The purchase needs a clinical purpose beyond a weight-loss headline. ^[1]

I would compare it when several of those services are actually missing. A reader satisfied with an existing clinician may need a narrower pharmacy or cost comparison instead of another continuing membership.

Keep the actual health outcome attached to weight loss, lean mass and function evidence.

Choose between standard care and a medicine-inclusive plan

The general FAQ lists a limited-time $39 promotion and a standard $135 monthly membership. GLP-1 medicines are generally additional on that route. Selected three-month compounded offers start at $151 per month equivalent for semaglutide and $216 for tirzepatide, subject to eligibility and actual plan conditions. ^{[1] [3]}

The separate Doctor + GLP-1 bundles include prescribed compounded medicine and delivery: semaglutide is $217 first month then $297 monthly; tirzepatide is $349 then $449. Certain higher-dose situations can add fees. Compare that selected bundle without assuming it needs an additional standard membership fee or guarantees a prescription. ^{[1] [4]}

Separate the selected care and medicine charges in the annual care-cost planner.

Keep coverage administration separate from clinical choice

Zealthy describes assistance exploring insurance coverage for prescribed branded GLP-1 medication. That can reduce paperwork, but the insurer still decides coverage and the reader remains responsible for applicable costs. A possible low copayment does not settle the actual bill. ^{[1] [4]}

Moving to a cash-pay compounded preparation changes the product being assessed. Compounded products do not receive FDA premarket approval; FDA recommends them for medical needs an approved medicine cannot meet. The provider should establish that rationale rather than choose a preparation because its advertised price is smaller. ^[5]

Compare a different coverage-support and care package in our Noom Med review.

The dated advertising warning has a specific meaning

FDA’s September 9, 2025 warning letter concerned advertising that implied compounded semaglutide was equivalent to approved medicines. It was not a product contamination test or a clinical-outcome comparison. Later resolution is not established here. ^[2]

The practical consequence is to keep the exact formulation and dispensing arrangement visible. A shared ingredient and a familiar brand reference do not prove equivalent outcomes. Weight reduction also should not be turned into a promise of preserved muscle, fewer cardiovascular events or longer life from using this service.

For a separate compounded-care and commitment model, read our Novi review.

The financial exit affects continuing care

The FAQ says memberships cannot be paused, while shipments can be delayed. It says canceling ends GLP-1 prior authorizations, refills and ongoing provider monitoring. That makes a continuing clinical arrangement important when stopping a subscription rather than simply stopping a parcel. ^[1]

The policy renews the chosen term automatically and generally does not prorate an unused current membership period. Prescription refund wording refers to issuance and filling in one place and shipment in another; the selected order’s cutoff needs clarification. A larger medication supply can also require multiple months of membership. ^[4]

For another continuing-care and refund arrangement, compare our WeightWatchers Clinic review.

Clarify the exception and the actual contact arrangement

The Doctor + GLP-1 FAQ offers a full refund for clinical ineligibility for semaglutide or tirzepatide. The general policy otherwise makes visit and membership fees nonrefundable. Establish the selected bundle’s terms before relying on that conditional promise, rather than assuming every unsuccessful or disappointing purchase is refundable. ^{[1] [4]}

The FAQ describes unlimited provider messaging and monthly video or phone visits, subject to provider discretion and clinical appropriateness. I would compare the service for useful ongoing contact. LifeMD is a separate clinical-access option to assess if a different branded-prescription arrangement fits; its medicine scope and fees need their own review. ^[1]

For the separate clinical-access comparison, see our LifeMD review.

Compare the actual purpose and complete commitment in our service comparisons.

For a separate recurring care purchase and its refund conditions, read our MyStart Health review.

Understanding the cost

Standard membership promotion $39; standard membership $135/month, with GLP-1 medicine generally additional. Selected three-month compounded offers start at $151/month equivalent for semaglutide or $216 for tirzepatide, subject to eligibility and actual plan. Separate Doctor + GLP-1 bundles: semaglutide $217 first month/$297 ongoing; tirzepatide $349 first month/$449 ongoing. Higher-dose exceptions may add fees. Bundle eligibility-refund wording must be reconciled with the general nonrefund policy. No universal complete treatment total. ^{[1] [3] [4]}